Unrestricted Research Grant Agreement between ARCA Discovery, Inc. and University of Colorado Foundation (July 27, 2007)

Summary

ARCA Discovery, Inc. agrees to provide the University of Colorado Foundation with an unrestricted research grant totaling $287,000 annually to support Dr. Michael Bristow's laboratory and heart failure research. The funds are allocated for lab personnel and general laboratory costs, and will be paid in monthly installments of $23,917. ARCA may terminate the arrangement at its discretion based on its financial condition. The agreement is effective as of July 1, 2007.

EX-10.14 15 dex1014.htm UNRESTRICTED RESEARCH GRANT WITH THE UNIVERSITY OF COLORADO, DATED JULY 27, 2007 Unrestricted Research Grant with the University of Colorado, dated July 27, 2007

Exhibit 10.14

1200 17^th Street, Suite 620

Denver, Colorado 80202

Phone: 303 ###-###-####, Fax: 303 ###-###-####

July 27, 2007

Michael R. Bristow, M.D., PhD.

Division of Cardiology

University of Colorado Health Sciences Center

Denver, CO 80262

Dear Michael,

ARCA Discovery, Inc. wishes to make unrestricted gifts to the University of Colorado Foundation in support of your laboratory and the research associated with heart failure. We direct these contributions to be allocated as summarized below.


• Lab Personnel Costs -	$	197,000	annually
• General Laboratory Costs		90,000	annually

Total Commitment	$	*287,000*

ARCA expects to fund this commitment through monthly payments of $23,917. These payments are contingent upon ARCA’s financial condition, therefore this arrangement can be terminated at ARCA’s discretion. The effective date of the arrangement is July 1, 2007.

Sincerely,

/s/ Richard B. Brewer

Richard B. Brewer

President & CEO


Acknowledged:		/s/ Michael Bristow
		Michael Bristow, M.D., PhD.

ARCA Discovery, Inc

INTERNAL USE ONLY

(Annual Costs)


*Name*	*Estimated Percentage of Salary Supported*	Amount of Contribution
[ * ]	[ * ]	[ * ]

[*]	Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities and Exchange Act of 1934, as amended.